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Abstract
We have recently identified the human homologue (LOTI, Lost On
Transformation 1, GenBank accession #U72621) of a rat gene (LotI, GenBank
accession #U72620) whose expression is frequently lost, or aberrant decrease,
when rat ovarian surface epithelial cells undergo spontaneous malignant
transformation. The deduced proteins encoded by the human and rat genes
contain seven zinc finger domains plus additional regions, suggesting that
the proteins are transcription factors. Using Fluorescence In Situ
Hybridization (FISH) analysis, LOTI has been localized to chromosome 6q25-
6q24. Since loss of heterozygosity in this chromosomal region is a frequent
occurrence in ovarian cancer, it is pOSSible that LOTI is the targeted gene. To
facilitate investigation of this possibility, we have determined the genomic
organization of this gene. This was accomplished by a combination of PCR
and genomic cloning techniques. PCR fragments generated from human
genomic DNA with primers designed using LOTI cDNA sequence suggest
that introns are not present in most of the open reading frame of LOTI.
. However, the 5'-portion of the gene could not thoroughly be studied using
this strategy, which suggested the possibility that intron(s) are present in this
area. Direct sequencing of genomic clones isolated from a human DNA
libraries confirmed that introns were not present within the majority .of the
open reading frame and its 3' end. As anticipated by the PCR data, further
analysis by this strategy revealed one intron residing within the nuc1eotides
definihg zinc-finger two and four introns within the 5'-untranslated.region of
the gene. Knowledge of the genomic organization of LOTI will allow human
tumor DNA to be examined for mutations and clarify whether this gene is
involve-d-in-the'eti0logy=an.d-/or-progression .0fQyarii:!.n.<::an£er or other solid
1
tumors where loss of DNA from the 6q25-6q24 chromosomal region IS
frequent.
2
Introduction
Every year, approximately 26,000 women· are diagnosed with ovarian
cancer and 15,000 women die from complications associated with the disease
(1). The cause of this disease, which arises as a result of the malignant
transformation of the ovarian surface epithelium, is largely unknown. It is
known that ovulatory frequency is a physiological factor contributing to the
disease, however, only recently have some genes and chromosomal regions
of possible relevance to the disease process been identified (1,2) .
The aspect of ovulation believed to be critical to the disease process is
the requirement for growth of surface epithelial cells to repair the wound at
the site of ovulation (3). A strategy to examine the role of this repetitious
requirement for growth in malignant transformation of ovarian surface
epithelial cells can be carried out by isolating rat ovarian su.rfaceepithelial
cells and subjecting them to growth stress in vitro by repeated subculture (4) .
This experimental procedure frequently results in malignant transformation
(5) and allows the genetic events that lead to multiple independent incidents
of transformation to be examined in the context of cells which initially had
the identical genetic background (6,7). We have used this model to identify a
rat gene, Lotl, which frequently displays decreased, or disregulated, expression
in transformed rat ovarian surface epithelial cells (6). We have recently
cloned the cDNA for human LOTI and have demonstrated that the gene is
localized to chromosome 6q25-6q24. This chromosomal region is a frequent
site for loss of heterozygosity in many solid tumor typ~s (8-11) including
ovarian cancer (6, 12). The location of LOT1, the pattern of its expression in
malignant cells, and thech~racteristics of the predicted protein which
contains zinc;.finger motifs and activator/repressor domains make it an
. .~ 3
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interesting candidate to consider for the probable tumor suppressor gene
targeted for inactivation by deletion of genetic material at chromosome 6q25.
In order to identify mutations andI or inactivating methylation differences,
the genomic sequence of the tumor suppressor gene must be ascertained.
Here we report the genomic structure of LOT1.
4
Materials and Methods
peR analysis of Human Genomic DNA to Determine. LOT1
Structure/Sequence. The following primers were synthesized based on the
DNA sequence of LOT1 eDNA: p47(5'-TCA CCT GTG GGG TCT GTG CCC T--
3'), p48(5'-TTG GGC GCA AGG ATC ACC TCA C-3'), p49(5'-CAC CCT CAG
TCC CCC AGA ACA AG-3'), p51(5'-GCT CCT GTG AGT GGG TCT TCT TG-
3'), p52(5'-CTG CAT AGG CTG GGC GGC TTG T-3'), p53(5'-CCC TTA GCC
AGA TCA AAA CCT GG-3'), p54(5'-AAC CTG TGG GGC AAA GAT TCC CC-
3'), p63(5'-TGG GTG TGA GGA GTG TGG GAA GA-3'), p69(5'-GCA GTT TGA
TTA CAG AAC ACG CG-3'), p75(5'-CTT TCA CAG TGG TCG CAC TGG-3'),
p95(5'-GCA CCA TCG TTC TGT TTG TGC-3'), pZ2(5'-GGC ACA GCA TTT
GGT CAG CAC-3'), p898(5'-GCT TCT TTT CCT TGG TTC CGC-3'), p95r(5'-
GCA CAA ACA GAA CGA TGG TGC--3'), pE1(5'--CTA CCT TCA GGG
TTG GAT GTA G--3'), pE2(5'-CAG GGT TGG ATG TAG TTT AGT TAC-
3'), pE3(5'-CGC GTG TTC TGT AAT CAA ACT GC -3), pA (5'-AGT GCT
CAC TGC TCT ACT CCC C -3'), and pC(5'-GCT GTC ACT AGC TTT GCT
GTG T-3') TH1341 (5'-AGA CAA ACT TCT GGG AGG ACT C-3') and TH1206
(5'-TGA ACA CTC GTC CGA GAA TAA CGA GTG GAT CTC GGT -3').
Various combinations of these primers were examined for their capacity to
amplify 100 ng of human genomic DNA by PCR while others were used for
DNA sequencing. A similar strategy was recently used to aid in defining the
genomic structure of MUTS (13). The conditions for the PCR were as
follows: nineteen cycles of 94°C-15 seconds,65°C-1 minute (-.soC/cycle), and
72°C-1 minute. After these initial nineteen cycles; twenty-five cycles of 94°C-
15 sec, 55°C-l min and 72 °C-l.minwere use_c!,--aft~k}Ylli!;:h---the.. xeaction.was----...-.---.-.~ ..----
-" _.- ------- ".... - ..---~-"------'-:::-:~"'.~'-"" _ "-.""-~' :~",;c.r.~i£~j;'-,:~~;-~--:::::~'::~:':'::':'--~::~-~~.~:",- ... - --_.:.__.._-:'-.-. . ~
extend~d for 5 minutes at 72°C. Aliquots of the reactions were visualized by
5
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agarose gel electrophoresis (2%,wIv). PCR products were purified (Wizard
Plus DNA purification system, Promega) according to the manufacturers
instructions and subjected to automated fluorescent-based DNA sequencing
(model 373A Automated Sequencer, Applied Biosystems) utilizing nested
primers (see above).
In instances where long range PCR was performed (>1.2 kb), PCR
conditions were the same as the "touch-down" program described, but an
extension time of 3 minutes at 72°C was used.
Isolation and Characterization of Genomic Clones Containing Portions
of the LOT1 Gene. A human placental genomic DNA library [EMBL-
3(SP6/T7), Clontech] was screened by standard methods (7) with Fl and RU5
PCR fragments which contained the majority of the open reading frame
(bases -271 to +1623) of LOTI in fragment Fl and the 5' untranslated region
(bases -271 to +1) in RU5. The genomic library was also screened using the
-1.2 kbp PCR fragment FB2-5' (discussed below). Bacteriaphage clones were
grown and purified by standard methods (14) . 'Phage inserts were sequenced
with the aid of polylinker specific primers (EMBL-3, SP6/T7) and primers
based on the cDNA sequence of tOT1. Additional insight into the genomic
structure of LOT1 was gained by analysis of the fragment sizes generated from
PCR when phage were used as template in combination with LOTI cDNA
based primers and/or phage specific primers.
. .
. .
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screened using the 1.2 kb FB2-5' fragm~nt. This fragment was generated from
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a new human partial LOT1 cDNA clone and contained bases -1547 to -567
with respect to LOT1's open reading frame. The resulting P1 done (clone
17513) was purified by standard means (QIAGEN Plasmid Purification Kit,
QIAGEN Inc.) and used in subsequent analysis.
Restriction Digests and Southern Blotting. (\ total of lug of purified PI DNA
was digested overnight with 20 Units of various restriction endonucleases
(Sail, Sad, PstI, XbaI, NotI, BamHI) before being electrophoresed on 0.7%
agarose gels. Gels were stained and DNA fragment sizes recorded before being
transfered overnight onto nylon membranes (Genescreen Plus, NEN Life
Sciences) under denaturing conditions (0.4 M NaOH). Blots were fixed for 45
seconds in the microwave before being prehybridized (0.2ml/cm2) at 65°C
overnight in Church Buffer (0.5 M NaP04, pH 7.1, 2 mM EDTA,7% SDS, 0.1
% Sodium Pyrophosphate). Southern blots were hybridized with end labeled
probes (see below) in fresh Church Buffer (0.2ml/cm2) at 37°C for 5 hours
before being washed at 37 °C two times for 10 minutes in 5 x ssc / .1 %SDS.
Fragments of interest were eventually cloned into pBluescript (Stratagene, La
Jolla, CA) and sequenced.
Preparation of Probes. F1 and RU5 fragments were generated from clone FB4
(a plasmid containing the complete open reading frame for LOT1, (6) ) by PCR
using primers p57 (5'-GGT CTC CCT CCC CAG AAG CCC T-3')/p69 (5'-GCA
GTT TGA TTA CAG AAC ACG CG-3') and primers p57/p60 (5'-TGG GCT
TTG CTT CTC ACA CCT TC-3'). Fragment FB2-5' was generated ftom clone
...
. . FB2 by PCR using primers. TH1336 (5'- CCT CGT GTC ACA TCT GAA ACT -
~~~~'H}tEi:):~.fiS-:...~t:;'=:'~::;:.;T'::., 5i::~C~ ~-:-:::::...... , .• " .. .'~": - - .. ',_ .;....", ~~~~~t,r.:·;'i;;.t7~:;:~-.:... .,.,.!:t~-z:-~:~=,-i-~.~:.:,..·~ ...--~--......;.-:-:-::--~ __.__~_:.:_:.._ ..._, __ . ~ ..
. 3')/TH1340 (5'- CTG ~AG TCA TG~ GAT CCA GGA: CAe _3'). The PCR
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amplification of template (lOng) was under the following conditions: initial
denaturation at 94°C for 2 minutes followed by 30 cycles of 94°C-25 seconds,
55°C-40 seconds, 72°C-2minutes.. The reaction product was purified (Wizard
, .
Plus DNA purification system, Promega) and labeled with a-32p by random
priming (Prime-IT II, Stratagene). For applications involving end labeling
(y_32p), oligonucleotides specific for the extreme 5' region of LOT1's cDNA
and adjacent to intron 4 (THl408/THl339) were end labeled using the T4
Kinase Kit (Gibco BRL).
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Results.
Genomic DNA Analysis by PCR. Initial Southern blot analysis
suggested that the majority of the ORF of LOTl contained no introns or
introns of small size (data not shown). To examine this possibility further,
primers designed from the cDNA sequence were used to amplify portions of
the LOTl gene from genomic DNA. This strategy allowed us not only to
determine the fragment sizes, but also allowed us to subject fragments to
sequencing in order to determine if small introns might exist within the
sequences of DNA analyzed. Six primer pairs (p63/p51, p49/p54, p53/48,
p52/p47, p54/p47, and. p63/p69; Figure 1) gave unambiguous results with
regard to fragment sizes when the PCR products were examined by
electrophoresis (Figure 1). The PCR product generated by the p63/p69 primers
encompassed the majority of the open reading frame and, thus, was purified
and sequenced. Sequence data did not reveal any evidence of introns from the
'" .
region of the gene encoding zinc-finger four to the end (3' end) of the open
reading frame (data not shown). Efforts to use this approach to clarify the·
genomic organization of the 5' portion of the LOTl gene, Le. upstream from
zinc-finger four, yielded in no peR product being formed.
Genomic Cloning and Characterization; Probe F1, which spanned the
open reading frame of LOTl , was used to isolate a member (L-1a) of a human
genomic placental DNA library. The phage clone contained an insert ~14 kb,
which was partially sequenced using primers .specific for the open reading
frame of LOT1. Figure 2 displays the extent of the overlap betw~en clone L-1a
~
and the genomic organization of LOTl which was eventually ~lucidated.
•
. .
Sequence data based on phage clone L-1a indicated that the sequence between
+153 (based on cDNA translation start site) and the last polyadenylation signal
was devoid of introns. This finding was consistent with the previous PCR
based strategy characterizing the genomic structure within the majority of the
open reading frame. The area upstream of zinc finger #2 (+153 within cDNA)
in clone L-1a was found to diverge from the known cDNA sequence and
displayed characteristics of a 3' intron splice site.
Characterization of the 5' protein of the LOTl gene was aided by
analysis of an additional LOTl cDNA clone (FB2) . This clone contain
variations in the 5' UTR from that reported in GenBank (accession #U72621).
As described below, use of FB2 to define the remaining exonic sequence of the
LOTl gene yielded unambiguous results, i.e. all exonic sequences could be
.accounted for in genomic DNA, in contrast to the use of data in GenBank. We
speculate that the 5' UTR region of the GenBank entry, which diverges with
cDNA clone FB2, is either a chimeric cDNA clone or an alternative transcript.
To substantiate the validity of this new cDNA clone, FISH analysis of a -1.2 kb
fragment (FB2-5') derived from this clone was localized to chromosome 6q24
(data not shown).
We next isolated clone L-8a from the human placental genomic library
using probe RU5, generated from bases -271 to +1 of the LOTl cDNA (Figure
3). This phage clone was purified, partially sequenced, and used to confirm
the existence of an intron within zinc finger #2. PCR analysis on clone L-8a
using primers flanking this intron have shown this intron to be -5.5kbp in
size (data not shown). Subsequent sequencing reactions upstream of this
intron identified sequence consistent with the cDNA as well as divergent
.. _~ .. sequen<;e.~-~Atthis~pointof divergence, sequence-Was characteristic of a 3'
10 r _~
intron splice site. peR analysis of this clone using LOTl specific prImers
downstream of this proposed 3' intron boundary and EMBL 3 SP6 primers
produced a product --4.5 kb in length (fragment f58La, Figure 2). Its sequence
defined the 5' end of clone L-8a and was considered intronic based on
divergence from the eDNA.
We next used the FB2-5' fragment described above to screen the human
placental genomic library. One positive phage clone (L-2a, Figure 2) was
isolated and a portion of it amplified using TH1341 and EMBL3 sp6 primers.
The resulting --3 kb fragment was cloned into pGEM-T vector (Promega), and
sequenced, enabling the 5' end of this intron to be defu1.ed. However, this
subclone (pL2-13) and phage L-8a did not span the length of the intron. To
obtain the approximate size of this intronic region, long range PCR was
performed with genomic DNA from normal individuals and primers
designed using sequence from the 5' 'region ofclone L-8a and the 3' region of
clone pL2-13. A 6 kb product (fragment fTH1143) was consistently generated,
whose sequence overlapped with the 5' and 3' region of clone L-8a and clone
pL2-13. Through addition of these regions, the size of this intron (intron 4)
has been estimated to be 12 kb.
The remainder of the L-2a phage clone was characterized in a similar
manner using PCR and a combination of LOTl eDNA specific primers and/or
EMBL3 T7 specific primers. In this manner, amplification of portion of clone
L-2a with primers TH1338 and TH1340 (Figure 3) consistently produced a --lkb
, .
fragment devoid of introns as determined by sequence analysis. Similar,
amplifications using TH1405R/TH1407 produced a 2.8 kb fragment," which
was cloned (subclone pTH1407). Sequence analysiS of pTH1407 showed "
: - - ". .
characteristics of exon/intron splice sites within the region encompassed by
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the TH1405R/TH1407 primers. PCR reactions using primers TH1405/EMBL
T7 resulted in the 4.5 kb product which was cloned (pGEM-T). Sequence
analysis of this clone (pT1, Figure 2) showed it to contain sequence
homologous to FB2 (near the TH1405 primer site) and also contained
sequence divergent with respect to a punitive 3' intron splice site (intron 1) .
PCR reactions using TH1405 in combination with further upstream LOTl
specific cDNA primers failed to produce a product using either clone L-2a or
normal human genomic DNA as templates, indicating the possible existence
of an intron of substantial size upstream of the TH1405 primer site. Similar
difficulties arose when attempting the amplification of the region between
primer sites TH1408 and TH1339 using clone L2-a DNA. In both PCR
reactions, products were not generated, regardless of altered extension times
and enzyme type.
To resolve remaining issues with regard to LOT1 genomic
organization, a human genomic P1library was screened (Genome Systems)
using the FB2-5' fragment, this resulted in the identification of P1 clone 17512.
This P1 clone was digested with a number of restriction enzymes, southern
blotted and probed with various LOT1-specific primers to validate the use of
this clone for further analysis (data not shown). Restrictions fragments
hybridizing to these primers specific for the regions upstream of primer
TH1405 and between primers TH1408 and TH1339 were then eventually
cloned into pBluescript. The sequence data produced on these clones
hybridizing to primer TH1536 (pSAC9 and pNOT2) allowed us to characterize
the 5' end of intron 1. Sequence data produced from genomic subclones
pSAC3 and pXBA4.2, which hybridize to primers TH1339~ and TH1408
respectively, verified the. e'4stence of intron 3.
12
Discussion
The LOTl locus has been demonstrated to have a minimum size of 24 kb and
composed of six exons and five introns. This was elucidated by screening 'a
human genomic PI (Genome Systems Inc.) and human genomic
bacteriophage (Clontech) libraries with various LOTl eDNA fragments. All
intron donor/acceptor sites follow the GT-AG rule (Table 1). The translation
initiation codon (ATG) of LOTl is located in exon 5, and encodes zinc finger
one and approximately half of zinc finger two which is interrupted by intron
five (5.5 kb). The remainder of the open reading frame coding for zinc fingers
2-7 and the proline/glutamine regions, is located in exon 6. This last exon
contains the 3' VTR of the gene which also processes five polyadenylation
signals (AATTAAA and ATTAAA). A CpG island is present in the sequence
we define as exon 1, and extends into the 5' flanking region of the gene. A
classical TATA box element is not present. Therefore we cannot define with
certainty the start site of transcription. We assume however that the sequence
shown in Figure 4 contains this area. This notion is based on analysis of this
sequence using the MatInspector (version 2.2) promoter database program,
which has identified a number of transcription factor binding sites, including
SPl, API, AP2, AP4, cAMP responsive binding protein, c-Myc and a
CCAAT/ enhancer binding protein element (Figure 4). These transcription
factor binding sites are of course characteristic of the region 5'of the start site
of transcription. RNAse protection assays and promoter reporter constructs
will be used in the future to further elucidate the transcriptional start site and
promoter ac~ivity of this region.
".-
~
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In summary, we have demonstrated that the genomic structure of the
translated portion of LOTI and its 3' region is relatively simple. This portion
of the gene contains only one intron, which is located within sequence
defining zinc-finger #2. Ongoing work will clarify the genomic organization
with. respect to alternative transcripts and the gene's regulatory elements.
Finally, the data presently available will facilitate analysis of tumor DNA for
mutations in this gene.
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Figure 1 :PCR Analysis of the LOT} Gene. 2% agarose gel depicting the PCR
amplified regions of LOT}. 100bp marker (Lane 1) and 1 Kbp marker (Lane 8)
were used as size standards. Lane 2 (p63/p51), lane 3 (p49/p54), lane 4
(p53/p48), lane 5 (p52/p47), lane 6 (p54/p47), and lane 7 (p63/p69). Fragment
F63/69 (lane 7), spanning the majority· of the open reading frame and parts of
the 3' untranslated region, was later used for direct sequencing. The primer
combinations used and the PCR product sizes are listed above. PCR reactions
on genomic DNA utilizing primer combinations p95/p75 failed to consistently
produce product (data not shown).
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Figure j : Analysis of the Gene. gel depicting the peR
ified of LOTI. lOObp marker (Lane and I Kbp marker ILme S
were used as size standards. Lane 2 (p63/pSI). lane 3 (p49/p54L lane -+
ip53/p48 lane 5 fp52/p47 lane 6 (p54/p47).and lane 7 (p63/p69). Fragment
F6.3/69 lane spanning the majority of the open reading frame and pan"
the .3' umranslateq regic?n.w£~.lalerused for direct sequencing. The primer
combinations used and the peR product sizes are listed above. peR .
on genormc DNA utilizing primer combinations p95/p75 failed to CO]rblstenill
produce not sho\vnL
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Figure 2: Genomic organization and contig map of the LOTt gene. Exons are shown as boxes while
introns are shown as solid lines. Genomic phage clones (L-8a, l-1a, and l-2a) and subclones derived
from phage and P1 clone 17517 which overlap with the LOTt gene are represented as horizontal
lines. PCR fragments (f58La and fTH1143) which were used for sequencing are also displayed.
~
-2041
-1961
-1881
-1801
TIl1536
GCCGTGCTCA CAGCTCAGCA GCGCGGGGCC TTGGCGCGCG GGGCGCTTCC CCGGGTCGCC GTCATGGCCG CGGAGGTGGC
ACGCCCGAGC GGCCTCGCCT GAGCTCCGGG GGTCGTCGCC CCGCA~AT TGCTGTCACG 1CTAATGTGG CTGCTGCCTC
TIll405 y -
GTGTCACATC TGAAACTCAT CTGTACCTCA CTTAGAAAGT GGTTCTGATT AGACAAGACT TTTCGTTGCA GTCGACAGAA
THl405R
ACCTAATGGG ACCATTGAAG AATTCCAAAC AGGCAAGTGA CAGGAACATA TTTGCATGTT AGAAGAATCA GCCTGGCAGC
-1721 AGCATTGTGA TTAGAATGAA GGGGAACCGT CCAAAAACAG ACTGGGGAAC CAATATGGAT CTGCCTCTAG CATGCGGAAA
~1641 TATCTCTCTA CACTGACCTA ACTGACTCAC TAAGCTTGTG GTTTGTTTAA AGGAAGCCAC ATGAAAATTG AGTTTGGGCC
TIll407
-1561 AATAGAGTGA ACTCGTTCTC CATTCTCTAG CATCCCTCCC CATGCAACCA CCCTATCCCT GCCAAGTTTC TGGGCACCAC
TIl1338
-1481 AGATTGGAAA GTAGCCTCCT GTAGGTATTT GCCCATGTTA AGTGGTGGGG TCTCTTTCTG TCTTCCCTTC TTGGTCTCAC
-1401 CTGTCTGGTG TGACAAGGGA AGCATGTGCC AACCAAGGCT AGACCCTTGT GAGACCAGAG CAGCCCCACT TTCGGTAAAG
-1321 CAAGCAACCT CTGCTTACTT GCCCAACACA CCCTAGCTTC CGTGTTCCTT GCCTTGTGAG TTATCTTCTT GGGTACAATT
-1241 TAACACAGCG TTCCCACCTC CTTATAACTA AAATAGCTAG AGGGGGCTTT GTGCCTCAAA CCCCAAGGAG ACCATCTTGG
-1161 CAATCTCTGC CTCTGCAACA GGGCACTTGC TCCCTGGGCA ACTCCTTTCC CAGGTCATCT TCTCCCTTGA CATGCCCATC
-1081 AGATTTAATA GTGTGCCTAT TTGGCAGAAA AATGGGGTCC CTTGGTTGCT GATTCTTAGG AATGTGAGGT TCTCCCAGCC
-1001 AGAGCTCTCA GCACTAAAAG TTCTAGTCTC TGCGTAATGG CCGGCATATC TTTGGCGTAT CTAAAATCCT CTTCAGTTTC
-921 CAGCAGGGTC TTTATAAGCT TCTTCTGAAG GTCTCAGACA TTCAGCCACGGAACTCAAGT GGAATTTGTT TGGATAACGT
-841 GACTGATTTC AAAGCCCGGA CCCTTAGACG TGCCCATTTG GTGCTGCAAG TACTGAACAT TACTACAACA TCTTACAGTC
-761 AACAAATTTG ACACATTAAA GATTTATATC CTTTCTTTTG GGTTAGGATC TTCTCTCCCC TAAAGCATCT CAGTTTCCAG
-681 CATGCAATCA TTTCCATCTT ATGGAAATCA GCCATCCCGC TCCGTGCCAG CATGCTACCC TGGGAGGCAC ATCCAGGCTT
1111340
-601 GGGAAACGGG GGTGTCCTGG ATCTCATGAC TCCAGCAGCA CCAGCTGCTC TCTTTCCTCT TCCAAGTAGA CTTCCGTTCC
TI:l1339
-521 CCCCCCACTT GGGTGTTTTT GTTTGTTTTA GCAATTCAGA GCTCAAGATA AAGACCTTAA AGATAACTTT GTGTGTCTCT
, TI:l1408
"-441 CCCTTTCTAG GTATTTGCAT AGGAATCAGA GGAGTTAATC TTGTTTGAAT CTTCAGACAA ACTTCTGGGA GGACTCGGTC,
-361 CCTGCCTCGC AGCAGATGTT TCCCTGTCAC TCAGTAGCCA ATCCGGGGGA CCCAGGACAT GCCCCAGCTA TAGTGATGCA
-281 GATTACCTTT CTGCTCCTGA ATCGCACCTG TGCCTCAGAC TTTCTCCCCT CAGCTTGAGA CTGCATGTAA ACTGGGATGT
-201 GTGAAAGCAG GAAGCAAAGC TAGTGACAGC TGAGAGGTCC ATGTCTGGGT AGAACCAGGC CCACGATGCT GCCTCTCCCG
-121 TGTTCTGGAG TTCAGCTGCA GGGATTCTGC TGATGTGCCC AGCACCATCG TTCTGTTTGT GCTTAAATGG CACAGCATTT
-41 GGTCAGCACA TCTGAAAAGG AAGGTGTGAG AAGCAAAGCC CELGGCCACG TTCCCCTGCC AGTTATGTGG CAAGACGTTC
40 CTCACCCTGG AGAAGTTCAC GATTCACAAT TATTCCCACT CCAGGGAGCG GCCGTACAAG TGTGTGCAGC CTGACTGTGG,
120 CAAAGCCTTT GTTTCCAGAT ATAAATTGAT GAGGCATATG GCTACCCATT CTCCCCAGAA ATCTCACCAG TGTGCTCACT
200 GTGAGAAGAC
Figure 3. Partial cDNA Structure of LOT]. Shown are the first five exons and the
5' end of exon 6. The first codon of LOT] is located in exon 5 and is underlined.
Also included are the areas where introns are present, as indicated by inverted
arrows. Sense and antisense primers are also shown as solid lines below and
above the primary sequence (respectively) which were used to characterize the
gene.
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-2911
-2861
-2811
-2761
-2711
CCAAT/enhancer
I iGAGCTCCTTA CACCTCTCTT AATCTTTTTA CGTAATGCTT ATAGGCCTTT
, '.
cAMP Responsive Element
TAAAAAGCAC GTCTTTTAGG GAAGAAAGCA ATAGAGATTC CCTTCAGTTT
ATTTTTCTTA AATTCCAGTA ACATGAAAAA TTTGAAATTA TATGAAGCAG
OCT-l
i i
ACGT~GTGTG ATACCGT~T TAGAAAATTA CTTCTGTCTA CCCTTTCTGC
GATA-l AP-4
GTCTTCGTTT C~TCAGCTGT G~GACGGGTA TTTCTCCCAG TGTTGCTGTG
-2661 AGGATTACAC GTATTTACCT GCAAAGTGCT TAGGACAGTG CCTGGCTCAC
-2611 GGTCAGTGCT CACGTTTGGG CAGCTGCACT TGGGCGCTGC TGGCACAGNA
-2561 GGTAAGTTAG TTTGGCCTAT TGCAGCGTCC CAGCATCTGT CGCGTTTCTC
-2511 ATGTGTGATT GGGCTCTGGC GGCCCATCCT GGCGGAGACT TCGGCTAGCA
AP-2
-2461 GGCCCCGCTG CAGACCCCAG GCChGCTCGG GTCTACCTGC GCCAGCGCTG
AP 1 AP-,2- i
-2411 TACCTGGGCG ACCTTGGCTT TGCCCCCACC GGTGACCCGGCCCGCAGGAC
AP-4
-2361 GTGTGGGTGC CG~TCAGCTC C2CCCGCTTC GGCCGCCGAC CCCCAGCTCC
SPI c-Myc
iii
-2311 CCGGCGGGGC CTCCNTCTTG CCACGTGACG CCCCCGCCAG GGGCCCCAGC
-2261 GCCCTCCTCG CGGCCGCGCC GTTCCGGCTC CCAAGCCCCG CCTGCGCGCG
-2211 GCCTCCTCGG CGCAGCCATC CTCTTGGCTG CCGCGGGCGG CAAAGCCCAC
AP-l
-2161 GGCATCTGCC ATTiGTCATT CAdCCCGTCG GTACCGCCCC GAGCCTTGAT
GCBox
-2111 TTAGACACGG CTGGGGCGTG CTCTGGCCTC ACTCTCCGGG CGdGTGCTGG
-2061 ACGGACGGAC GGACGGGGCA GCNGTGCTCA CAGCTCAGCA GCGCGGGGCC
-2011 TTGGCGCGCG GGGCGCTTCC CCGGGTCGCC GTCATGGCCG CGGAGGTGGC
Figure 4: Nucleotide Sequence of the 5'· UTR and 5' Flankng
Region of LOT1. The numbering of nucleotides to the left of the
sequence corresponds to the first ATG start site. A number of
different transcription factor binding sites are also present, as
indicated by the boxed regions.
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Table 1: Exon/lntron Boundries and Exon Sizes of the LOTt Gene.
EXON EXON SIZE 3' INTRON/EXON SEQUENCE 5' INTRONIEXON SEQUENCE
1 --- --- CGCAGGgtaggtgttt
2 72 tttcctttagGATTGC AGAAAGgtaaatacgt
3 1443 caactttcagTGGTTC AATCTgtgagtatac
4 75 cttctcacagGTTTGA CAGTAGgtgcgcatgt
5 475 ctctccacagCCAATC GATGAGgtgagaggct
6 2380 ctgctcctagGCATAT TTGCAAtttggcttga
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